Find link

language:

Find link is a tool written by Edward Betts.

Longer titles found: Safety Pharmacology Society (view)

searching for Safety pharmacology 26 found (33 total)

IIT Research Institute (2,385 words) [view diff] exact match in snippet view article find links to article

and metabolism (PK/ADME) studies, reproductive toxicology studies, safety pharmacology studies, and studies involving a variety of specializations and clinical

Christine L. Mummery (1,068 words) [view diff] exact match in snippet view article find links to article

is leading in their use for cardiovascular disease modelling and safety pharmacology. In 2010, she established the LUMC hiPSC core facility. Mummery obtained

Nialamide (334 words) [view diff] case mismatch in snippet view article find links to article

Elsevier. pp. 2935–. ISBN 978-0-8155-1856-3. Gad SC (26 April 2012). Safety Pharmacology in Pharmaceutical Development: Approval and Post Marketing Surveillance

Song Jianping (435 words) [view diff] exact match in snippet view article find links to article

taken part in the research of preclinical efficacy pharmacology, safety pharmacology, pharmacokinetic/toxicokinetic, and drug metabolism studies and clinical

Zabofloxacin (385 words) [view diff] exact match in snippet view article find links to article

745137. S2CID 96104286. Kim EJ, Shin WH, Kim KS, Han SS (Nov 2004). "Safety pharmacology of DW-224a, a novel fluoroquinolone antibiotic agent". Drug Chem

Echocardiography (3,989 words) [view diff] exact match in snippet view article find links to article

cardiac function and morphology in preclinical drug toxicology and safety pharmacology". Expert Opinion on Drug Metabolism & Toxicology. 4 (6): 681–696

Ergotamine (1,415 words) [view diff] case mismatch in snippet view article find links to article

S2CID 22721405. PDSP Database – UNC Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

Bromocriptine (1,988 words) [view diff] case mismatch in snippet view article find links to article

1038/s41386-023-01567-7. PMID 36932180. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

Dihydroergotamine (1,090 words) [view diff] case mismatch in snippet view article find links to article

x. PMID 12558771. S2CID 21356727. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

John Maggio (pharmacologist) (114 words) [view diff] case mismatch in snippet view article

Retrieved 10 December 2018. "In Memoriam: John E. Maggio, PhD, DSP". Safety Pharmacology Society. Retrieved 10 December 2018. "John E. Maggio". Cincinnati

5-HT2B receptor (3,546 words) [view diff] case mismatch in snippet view article find links to article

nytimes.com. Retrieved 2022-07-04. Cavero I, Guillon JM (2014-03-01). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

2-Hydroxybenzylamine (238 words) [view diff] exact match in snippet view article find links to article

NN, Oates JA, Boutaud O, Rathmacher JA (November 2018). "In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate". Food and Chemical Toxicology

Pergolide (1,520 words) [view diff] case mismatch in snippet view article find links to article

1038/s41386-023-01567-7. PMID 36932180. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

Ergometrine (1,626 words) [view diff] case mismatch in snippet view article find links to article

ISSN 1569-7339. S2CID 241134396. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

Methylergometrine (1,185 words) [view diff] case mismatch in snippet view article find links to article

1080/02791072.1980.10471568. PMID 7420432. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

Cabergoline (3,011 words) [view diff] case mismatch in snippet view article find links to article

2013-11-08. Retrieved 2014-03-04. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

Amantadine (6,117 words) [view diff] exact match in snippet view article find links to article

"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans". Neuropharmacology. 142: 89–115

Memantine (6,296 words) [view diff] exact match in snippet view article find links to article

"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans". Neuropharmacology. 142: 89–115

Methysergide (2,495 words) [view diff] case mismatch in snippet view article find links to article

ISSN 1569-7339. S2CID 241134396. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

MDMA (15,980 words) [view diff] case mismatch in snippet view article find links to article

00899.X. PMC 2962814. PMID 20718737. Cavero I, Guillon JM (2014). "Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating

List of medical journals (360 words) [view diff] case mismatch in snippet view article find links to article

Taylor and Francis Group English 2005–present Expert Opinion on Drug Safety Pharmacology Informa English 2002–present Expert Opinion on Emerging Drugs Pharmacology

Microelectrode array (4,974 words) [view diff] exact match in snippet view article find links to article

and applied neuroscience as well as in industrial drug discovery, safety pharmacology and neurotechnology. The biannual conference has developed into an

Les Bursill (1,762 words) [view diff] no match in snippet view article find links to article

also completed qualifications in Workplace Occupational Health and Safety, Pharmacology (effects of drug and alcohol) and counselling. In 1990, Bursill entered

Murepavadin (1,186 words) [view diff] exact match in snippet view article find links to article

and in vivo properties of murepavadin combined with an appropriate safety pharmacology and toxicology profile led to the clinical development of murepavadin

Sonlicromanol (2,476 words) [view diff] exact match in snippet view article find links to article

on redox biomarkers were observed. Furthermore, non-clinical and safety pharmacology studies revealed no mutagenic or carcinogenic effects and no phototoxic

Pharmacological cardiotoxicity (3,566 words) [view diff] case mismatch in snippet view article find links to article

Journal of Pharmacological and Toxicological Methods. Focused Issue on Safety Pharmacology. 81: 354. doi:10.1016/j.vascn.2016.02.063. ISSN 1056-8719. S2CID 89280007